These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 28719898)

  • 41. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
    Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valsartan inhibits amylin-induced podocyte damage.
    Huang F; Wang Q; Ma X; Wu L; Guo F; Qin G
    Microvasc Res; 2016 Jul; 106():101-9. PubMed ID: 27102209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
    Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
    Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
    Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
    Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
    Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway.
    Jin LW; Pan M; Ye HY; Zheng Y; Chen Y; Huang WW; Xu XY; Zheng SB
    Exp Physiol; 2019 Feb; 104(2):220-230. PubMed ID: 30414341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-135 family members mediate podocyte injury through the activation of Wnt/β-catenin signaling.
    Yang X; Wang X; Nie F; Liu T; Yu X; Wang H; Li Q; Peng R; Mao Z; Zhou Q; Li G
    Int J Mol Med; 2015 Sep; 36(3):669-77. PubMed ID: 26134897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of renal corpuscle microRNA expression on epithelial-to-mesenchymal transition in maternal low protein diet in adult programmed rats.
    Sene Lde B; Mesquita FF; de Moraes LN; Santos DC; Carvalho R; Gontijo JA; Boer PA
    PLoS One; 2013; 8(8):e71310. PubMed ID: 23977013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.
    Abbate M; Zoja C; Morigi M; Rottoli D; Angioletti S; Tomasoni S; Zanchi C; Longaretti L; Donadelli R; Remuzzi G
    Am J Pathol; 2002 Dec; 161(6):2179-93. PubMed ID: 12466133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Logar CM; Brinkkoetter PT; Krofft RD; Pippin JW; Shankland SJ
    Kidney Int; 2007 Aug; 72(4):489-98. PubMed ID: 17554257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
    Wang J; Fu D; Senouthai S; You Y
    Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
    Cui X; Fu J; Luan J; Qi H; Jiao C; Ran M; Wang D; Hao X; Zhang Y; Kopp JB; Pi J; Zhou H
    Biochem Biophys Res Commun; 2020 Oct; 531(3):341-349. PubMed ID: 32800553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-30e targets BNIP3L to protect against aldosterone-induced podocyte apoptosis and mitochondrial dysfunction.
    Guo Y; Deng X; Chen S; Yang L; Ni J; Wang R; Lin J; Bai M; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F589-F598. PubMed ID: 27974319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased miR-128 and increased miR-21 synergistically cause podocyte injury in sepsis.
    Wang S; Wang J; Zhang Z; Miao H
    J Nephrol; 2017 Aug; 30(4):543-550. PubMed ID: 28497421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhodojaponin II attenuates kidney injury by regulating TGF-β1/Smad pathway in mice with adriamycin nephropathy.
    Qiu Y; Zhou J; Zhang H; Zhou H; Tang H; Lei C; Ye C; You C; Chen Y; Wang Y; Xiong J; Su H; Yao G; Zhang C
    J Ethnopharmacol; 2019 Oct; 243():112078. PubMed ID: 31301369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
    Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
    Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.